{
    "organizations": [],
    "uuid": "a32d118e25d373be408c371e7a4512089203198b",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/27/the-associated-press-xencor-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Xencor reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "MONROVIA, Calif. (AP) _ Xencor Inc. (XNCR) on Tuesday reported a loss of $11.8 million in its fourth quarter.\nThe Monrovia, California-based company said it had a loss of 25 cents per share.\nThe results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.\nThe biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $10.9 million in the period.\nFor the year, the company reported a loss of $48.9 million, or $1.05 per share, swinging to a loss in the period. Revenue was reported as $35.7 million.\nXencor shares have climbed 34 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $29.39, a rise of 19 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR",
    "published": "2018-02-28T01:27:00.000+02:00",
    "crawled": "2018-02-28T03:00:16.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "monrovia",
        "ap",
        "xencor",
        "xncr",
        "tuesday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "monrovia",
        "company",
        "said",
        "loss",
        "cent",
        "per",
        "share",
        "result",
        "surpassed",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "biotech",
        "developing",
        "antibody",
        "severe",
        "disease",
        "cancer",
        "posted",
        "revenue",
        "million",
        "period",
        "year",
        "company",
        "reported",
        "loss",
        "million",
        "per",
        "share",
        "swinging",
        "loss",
        "period",
        "revenue",
        "reported",
        "million",
        "xencor",
        "share",
        "climbed",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "tuesday",
        "share",
        "hit",
        "rise",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "xncr",
        "http"
    ]
}